Schizophrenia Trial, Recruiting NCT03649581 Sponsor: University Hospital, Strasbourg, France Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT03649581
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For both patients and people in the control group:

  • People who are willing to take part and have signed the required consent form
  • People who are male or female

For patients only:

  • People who are covered by health insurance
  • People who have been diagnosed with schizophrenia or schizo-affective disorder according to standard diagnostic criteria (DSM-5)
  • People who have been diagnosed with periodic catatonia or hebephrenia according to the WKL classification system (confirm with trial site)
  • People whose condition has been clinically stable for at least 2 months
  • People who may be either hospital inpatients or outpatients

For people in the control group only:

  • People with no history of psychiatric conditions

Who may not be able to join:

For both patients and people in the control group:

  • People who currently have a serious or unstable physical illness
  • People with a history of neurological conditions, such as epilepsy, brain injury, or brain surgery
  • People who currently have a substance use disorder (as defined by DSM-5 criteria)
  • People who currently have a major depressive disorder (as defined by DSM-5 criteria)
  • People with an intellectual disability (IQ below 70)
  • People who are currently pregnant or breastfeeding
  • People who are currently under a legal guardianship order
  • People for whom an fMRI scan would be medically unsuitable

For people in the control group only:

  • People who have taken any psychiatric or psychotropic medications within the last 3 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 88 11 64 62

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 February 2019
Est. completion
2 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Index of affect; Index of psychomotoricity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov